Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11755349rdf:typepubmed:Citationlld:pubmed
pubmed-article:11755349lifeskim:mentionsumls-concept:C0042071lld:lifeskim
pubmed-article:11755349lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:11755349pubmed:issue2lld:pubmed
pubmed-article:11755349pubmed:dateCreated2001-12-28lld:pubmed
pubmed-article:11755349pubmed:abstractTextThe identification of 2-pyridinylguanidines (e.g., 27 and 28) as selective inhibitors of urokinase-type plasminogen activator (uPA) is described. The X-ray crystal structure of 27 has been determined, and modelling has been used to predict binding in the enzyme active site.lld:pubmed
pubmed-article:11755349pubmed:languageenglld:pubmed
pubmed-article:11755349pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755349pubmed:citationSubsetIMlld:pubmed
pubmed-article:11755349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755349pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755349pubmed:statusMEDLINElld:pubmed
pubmed-article:11755349pubmed:monthJanlld:pubmed
pubmed-article:11755349pubmed:issn0960-894Xlld:pubmed
pubmed-article:11755349pubmed:authorpubmed-author:DickinsonRoge...lld:pubmed
pubmed-article:11755349pubmed:authorpubmed-author:BarberChristo...lld:pubmed
pubmed-article:11755349pubmed:authorpubmed-author:HorneValerie...lld:pubmed
pubmed-article:11755349pubmed:issnTypePrintlld:pubmed
pubmed-article:11755349pubmed:day21lld:pubmed
pubmed-article:11755349pubmed:volume12lld:pubmed
pubmed-article:11755349pubmed:ownerNLMlld:pubmed
pubmed-article:11755349pubmed:authorsCompleteYlld:pubmed
pubmed-article:11755349pubmed:pagination181-4lld:pubmed
pubmed-article:11755349pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11755349pubmed:meshHeadingpubmed-meshheading:11755349...lld:pubmed
pubmed-article:11755349pubmed:meshHeadingpubmed-meshheading:11755349...lld:pubmed
pubmed-article:11755349pubmed:meshHeadingpubmed-meshheading:11755349...lld:pubmed
pubmed-article:11755349pubmed:meshHeadingpubmed-meshheading:11755349...lld:pubmed
pubmed-article:11755349pubmed:meshHeadingpubmed-meshheading:11755349...lld:pubmed
pubmed-article:11755349pubmed:meshHeadingpubmed-meshheading:11755349...lld:pubmed
pubmed-article:11755349pubmed:year2002lld:pubmed
pubmed-article:11755349pubmed:articleTitleSelective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines.lld:pubmed
pubmed-article:11755349pubmed:affiliationDepartment of Discovery Chemistry, Pfizer Global Research and Development, Sandwich, Kent CT13 9NJ, UK. christopher_barber@sandwich.pfizer.comlld:pubmed
pubmed-article:11755349pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:11755349lld:chembl